Clinical Trial: Oral Antifibrotic Agents in Pulmonary Fibrosis(Japan)

Tokyo, June 2 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058009) titled 'Oral Antifibrotic Agents in Pulmonary Fibrosis' on May 29

Study Type:

Others,meta-analysis etc

Study Design:

Primary Sponser:

Institute - Kanagawa Cardiovascular and Respiratory Center

Condition:

Condition - Pulmonary Fibrosis (IPF/PPF) Classification by malignancy - Others Genomic information - NO

Objective:

Intervention:

Eligibility:

Age-lower limit - 18 years-old <= Age-upper limit - Not applicable Gender - Male and Female Key inclusion criteria - 1. RCT 2. Diagnosis with Pulmonary Fibrosis 3. Oral Antifibrotic Agents Key exclusion criteria - 1. Subgroup analysis without adding new information 2. Data n...